Pareon Biosystems
5 known investors
Find your way into Pareon Biosystems
Sign up to see every warm intro you have to Pareon Biosystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pareon Biosystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
Founders & leadership
GP

Guillaume ParéFounder & President
Investors · 5
Also in the syndicate · 3
IBMLama PartnersNorwestlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2026
Norwest (lead), IBM, Lama Partners, PICO Venture Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Pareon Biosystems do?
- Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
- Who founded Pareon Biosystems?
- Pareon Biosystems was founded by Guillaume Paré.
- Who are Pareon Biosystems's investors?
- Pareon Biosystems's investors include CABHI Ventures, PICO Venture Partners.

